Zobrazeno 1 - 10
of 38
pro vyhledávání: ''
Autor:
Richardae Araojo, Celeste Eng, Esteban G. Burchard, Ronald L. Rabin, P.F. Huang, Jose R. Rodriguez-Santana, Jonathan Witonsky, Maria G. Contreras, Donglei Hu, Eric M. Wohlford, Christine Merenda, Jennifer R. Elhawary, Scott Huntsman, Cecile T.J. Holweg, Sam S. Oh, Michael A. LeNoir, Luisa N. Borrell, L. Millette, Angel C.Y. Mak, Christine M. Lee
Publikováno v:
The Journal of allergy and clinical immunology, vol 148, iss 5
J Allergy Clin Immunol
J Allergy Clin Immunol
BACKGROUND: Asthma is a heterogeneous disease. Clinical blood parameters differ by race/ethnicity and are used to distinguish asthma subtypes and inform therapies. Differences in subtypes may explain population-specific trends in asthma outcomes. How
Autor:
Helen K. Reddel
Publikováno v:
Journal of Allergy and Clinical Immunology. 136:546-552
In their most typical forms, asthma and chronic obstructive pulmonary disease (COPD) are clearly distinguishable, but many patients with chronic airflow limitation demonstrate features of both conditions and have worse health outcomes than those with
Autor:
Stanley J. Szefler
Publikováno v:
Journal of Allergy and Clinical Immunology. 135:644-652
Last year's "Advances in pediatric asthma in 2013: Coordinating asthma care" concluded that, "Enhanced communication systems will be necessary among parents, clinicians, health care providers and the pharmaceutical industry so that we continue the pa
Autor:
Hekking, Pieter-Paul W, Wener, Reinier R, Amelink, Marijke, Zwinderman, Aelko H, Bouvy, Marcel L, Bel, Elisabeth H, Sub Pharmacoepidemiology, Pharmacoepidemiology and Clinical Pharmacology
Publikováno v:
Journal of allergy and clinical immunology, 135(4), 896-902. Mosby Inc.
Journal of Allergy and Clinical Immunology, 135(4), 896. Mosby Inc.
Journal of Allergy and Clinical Immunology, 135(4), 896. Mosby Inc.
Background Severe asthma is characterized by difficulty to achieve disease control despite high-intensity treatment. However, prevalence figures of severe asthma are lacking, whereas longstanding estimates vary between 5% and 10% of all asthmatic pat
Autor:
Kelly Duncan, David Diaz-Sanchez, David B. Peden, Michelle L. Hernandez, Allison J. Burbank, Ceila E. Loughlin, Katherine T. Mills, Robert B. Devlin, Carole Robinette, Krista Todorich, Marcia Frye, Radhika Dhingra
Publikováno v:
Journal of Allergy and Clinical Immunology. 142:1974-1977.e3
In a cohort of African American adolescents with persistent asthma on guidelines-based daily controller therapies, short–term elevation of low ozone levels below the National Ambient Air Quality Standard of 70 ppb were associated with lung function
Autor:
Heather Powell, Vanessa E. Murphy, Peter D. Sly, Daniel Barker, Matthew Morten, Peter G. Gibson, Christopher Oldmeadow, Joerg Mattes, Adam Collison, John Attia, Joseph Meredith, Paul Robinson
Publikováno v:
Journal of Allergy and Clinical Immunology. 142:1765-1772.e4
Background The single-center double-blind, randomized controlled Managing Asthma in Pregnancy (MAP) trial in Newcastle, Australia, compared a treatment algorithm using the fraction of exhaled nitric oxide (FENO) in combination with asthma symptoms (F
Autor:
J. Sebastiaan Vroegop, H. Jens Bos, Lolkje T. W. de Jong-van den Berg, Priscilla A. Zetstra-van der Woude
Publikováno v:
Journal of Allergy and Clinical Immunology, 131(3), 711-717. MOSBY-ELSEVIER
Background: It is important to control asthma during pregnancy. However, some studies indicate that women stop or change their asthma medications when they become pregnant. Objective: We used a population database to analyze changes in prescriptions
Autor:
Monika Bobrowska-Korzeniowska, Andrzej Blauz, Paweł Majak, Lukasz Pulaski, Blazej Rychlik, Agnieszka Brzozowska, Piotr Kuna, Izabela Kuprys-Lipinska, Iwona Stelmach
Publikováno v:
Journal of Allergy and Clinical Immunology. 125:1220-1227
Background Allergen-specific immunotherapy (SIT) is the only available potentially curative approach in the management of allergic diseases. Therapies that boost regulatory T cell induction during SIT might further enhance its effectiveness. Objectiv
Publikováno v:
Journal of Allergy and Clinical Immunology. 125:521-526
For children living in inner cities, asthma tends to be more frequent and severe. To characterize, understand, and treat children with asthma living in the inner city more effectively, the National Institute of Allergy and Infectious Diseases establi
Autor:
William W. Busse
Publikováno v:
Journal of Allergy and Clinical Immunology. 125:529-537
Asthma in inner-city children is prevalent, has increased severity, and for many patients poses difficulty in achieving control. Although some of the limitations to asthma control in inner-city children include socioeconomic burdens, other factors, s